(MYRG) MYR - Overview
Stock: Transmission, Distribution, Commercial, Industrial, Wiring
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 46.0% |
| Relative Tail Risk | -5.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.37 |
| Alpha | 69.98 |
| Character TTM | |
|---|---|
| Beta | 1.349 |
| Beta Downside | 1.095 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.29% |
| CAGR/Max DD | 0.82 |
Description: MYRG MYR January 12, 2026
MYR Group Inc. (NASDAQ: MYRG) delivers electrical construction services across the United States and Canada through two primary segments. The Transmission & Distribution segment acts as a prime contractor for utilities and related entities, handling design, engineering, procurement, construction, and maintenance of high-voltage transmission lines, substations, and lower-voltage distribution systems, as well as emergency restoration after extreme weather events. The Commercial & Industrial segment serves general contractors and facility owners, providing wiring, intelligent transportation systems, roadway lighting, and electric-vehicle charging infrastructure for a broad range of end-users such as hospitals, data centers, airports, and industrial plants.
Key recent metrics (FY 2023) show revenue of roughly $1.2 billion with an EBITDA margin near 7 %, reflecting modest profitability in a capital-intensive sector. Growth is being propelled by two macro-drivers: (1) accelerated grid-modernization spending by investor-owned utilities, which the U.S. Energy Information Administration forecasts to rise at a 5 % CAGR through 2028, and (2) expanding demand for EV-charging and renewable-energy interconnection projects, which have lifted the share of clean-energy work in MYR’s order backlog to over 30 %.
For a deeper, data-rich view of MYR’s valuation dynamics, you might explore the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 97.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 7.98 > 1.0 |
| NWC/Revenue: 7.61% < 20% (prev 7.61%; Δ -0.00% < -1%) |
| CFO/TA 0.14 > 3% & CFO 232.9m > Net Income 97.8m |
| Net Debt (42.8m) to EBITDA (198.5m): 0.22 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.6m) vs 12m ago -4.25% < -2% |
| Gross Margin: 11.34% > 18% (prev 0.09%; Δ 1125 % > 0.5%) |
| Asset Turnover: 217.0% > 50% (prev 222.0%; Δ -4.98% > 0%) |
| Interest Coverage Ratio: 21.35 > 6 (EBITDA TTM 198.5m / Interest Expense TTM 6.97m) |
Altman Z'' 3.08
| A: 0.16 (Total Current Assets 1.07b - Total Current Liabilities 800.9m) / Total Assets 1.65b |
| B: 0.28 (Retained Earnings 466.7m / Total Assets 1.65b) |
| C: 0.09 (EBIT TTM 148.9m / Avg Total Assets 1.62b) |
| D: 0.45 (Book Value of Equity 457.4m / Total Liabilities 1.03b) |
| Altman-Z'' Score: 3.08 = A |
Beneish M -3.38
| DSRI: 0.98 (Receivables 969.3m/998.5m, Revenue 3.51b/3.54b) |
| GMI: 0.75 (GM 11.34% / 8.50%) |
| AQI: 0.96 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.99 (Revenue 3.51b / 3.54b) |
| TATA: -0.08 (NI 97.8m - CFO 232.9m) / TA 1.65b) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of MYRG shares?
Over the past week, the price has changed by +7.49%, over one month by +14.15%, over three months by +15.16% and over the past year by +79.39%.
Is MYRG a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MYRG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 254.3 | -5.4% |
| Analysts Target Price | 254.3 | -5.4% |
| ValueRay Target Price | 382.6 | 42.4% |
MYRG Fundamental Data Overview February 04, 2026
P/S = 1.137
P/B = 6.2862
P/EG = 4.91
Revenue TTM = 3.51b USD
EBIT TTM = 148.9m USD
EBITDA TTM = 198.5m USD
Long Term Debt = 67.4m USD (from longTermDebt, last quarter)
Short Term Debt = 18.5m USD (from shortTermDebt, last quarter)
Debt = 119.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 42.8m USD (from netDebt column, last quarter)
Enterprise Value = 4.04b USD (4.00b + Debt 119.0m - CCE 76.2m)
Interest Coverage Ratio = 21.35 (Ebit TTM 148.9m / Interest Expense TTM 6.97m)
EV/FCF = 25.87x (Enterprise Value 4.04b / FCF TTM 156.1m)
FCF Yield = 3.86% (FCF TTM 156.1m / Enterprise Value 4.04b)
FCF Margin = 4.44% (FCF TTM 156.1m / Revenue TTM 3.51b)
Net Margin = 2.78% (Net Income TTM 97.8m / Revenue TTM 3.51b)
Gross Margin = 11.34% ((Revenue TTM 3.51b - Cost of Revenue TTM 3.12b) / Revenue TTM)
Gross Margin QoQ = 11.77% (prev 11.52%)
Tobins Q-Ratio = 2.45 (Enterprise Value 4.04b / Total Assets 1.65b)
Interest Expense / Debt = 1.21% (Interest Expense 1.44m / Debt 119.0m)
Taxrate = 28.25% (12.6m / 44.7m)
NOPAT = 106.8m (EBIT 148.9m * (1 - 28.25%))
Current Ratio = 1.33 (Total Current Assets 1.07b / Total Current Liabilities 800.9m)
Debt / Equity = 0.19 (Debt 119.0m / totalStockholderEquity, last quarter 617.6m)
Debt / EBITDA = 0.22 (Net Debt 42.8m / EBITDA 198.5m)
Debt / FCF = 0.27 (Net Debt 42.8m / FCF TTM 156.1m)
Total Stockholder Equity = 587.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.04% (Net Income 97.8m / Total Assets 1.65b)
RoE = 16.65% (Net Income TTM 97.8m / Total Stockholder Equity 587.5m)
RoCE = 22.73% (EBIT 148.9m / Capital Employed (Equity 587.5m + L.T.Debt 67.4m))
RoIC = 16.01% (NOPAT 106.8m / Invested Capital 667.4m)
WACC = 10.60% (E(4.00b)/V(4.11b) * Re(10.89%) + D(119.0m)/V(4.11b) * Rd(1.21%) * (1-Tc(0.28)))
Discount Rate = 10.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.65%
[DCF Debug] Terminal Value 59.49% ; FCFF base≈103.3m ; Y1≈67.8m ; Y5≈30.9m
Fair Price DCF = 24.29 (EV 419.8m - Net Debt 42.8m = Equity 377.0m / Shares 15.5m; r=10.60% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -19.09 | EPS CAGR: -18.66% | SUE: -2.28 | # QB: 0
Revenue Correlation: 68.42 | Revenue CAGR: 10.84% | SUE: 0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.03 | Chg30d=-0.024 | Revisions Net=+3 | Analysts=4
EPS next Year (2026-12-31): EPS=8.93 | Chg30d=+0.070 | Revisions Net=+2 | Growth EPS=+26.5% | Growth Revenue=+9.6%